The Future of Tissue Engineering and Cell Therapy to 2025

Market report presenting a detailed overview of the technical and clinical characteristics of the key tissue engineering and cell therapy methods and products

£4,200.00

Add to basket Enquire
Product detail
Product type: Market report
Date of publication: 01 May 2015
Product format: Digital Copy, Hard Copy
Number of pages: 376
Number of tables: 165
Number of figures: 24
Forecast range: 2015-2025
  • The global tissue engineering and cell therapy market stood at nearly $9.9 billion in 2014 and is forecast to see an annual average growth rate of 21% to reach a value of around $73 billion by 2025.
  • Anaylsis of engineered or regenerated biological tissues and the products used to create them, which are then applied to the treatment of disease and trauma types. It also covers cell therapy, including the use of stem cells to treat disease and trauma.
  • Detailed analysis of these applications used in virtually all areas of medicine, including cardiology, neurology, gastroenterology, gynaecology and various forms of cancer.  

Description

OUR EXCLUSIVE CONTENT

  • Statistical data for the size and scope of the market for tissue engineering and cell therapy products to 2025
  • Detailed examination of product type, medical end-use and geographical regions
  • Key trends, technologies and market influences

METHODOLOGY

The Future of Tissue Engineering and Cell Therapy to 2025 is based on extensive primary and secondary research from multiple information sources. Primary research consisted of surveys and interviews with marketing/sales executives and other senior management at tissue engineering and cell therapy companies; clinicians in this field and other stakeholders (regulatory, reimbursement, investment) within the industry. Secondary research was compiled using industry data such as company marketing literature, company annual reports, regulatory filings, peer-reviewed clinical publications and investment reports, amongst others. Statistical data from government and non-government sources was used to compile the report, as well as published coverage policies by major third-party players.  

WHAT WILL YOU DISCOVER?

  • A detailed overview of the technical and clinical characteristics of the key tissue engineering and cell therapy methods and products
  • In-depth analysis of the market dynamics as well as the current and anticipated development pattern for the tissue engineering and cell therapy industry
  • Quantitative market sizing including geographical breakdown to 2025 to drive your business towards growth  

WHO SHOULD BUY THIS REPORT?

  • Tissue engineering and cell therapy product manufacturers
  • Medical and surgical instrument manufacturers
  • Clinical suppliers
  • Raw material suppliers
  • Research/testing laboratories
  • Consultants and analysts
  • Venture capitalists and other investors   

WHAT'S INCLUDED IN THE PRICE?

  • An electronic version of the report in PDF format. You may add a hardcopy version (mailed to you) - see the order form for details
  • 10-year market forecasts
  • Analyses of key trends, strategic market forecasts and extensive tables and figures

Table of Contents

Executive summary

Objectives, scope, methodology and definitions

  • Objectives
  • Scope of this report
  • Methodology
  • Definitions

Background

  • Overview
  • Tissue engineering supportive technologies
    • Biomaterials scaffolds
    • Nanotechnology
    • 3-dimensional bio printing
    • Microfluidics
    • Bioreactors
    • Cryopreservation and storage technologies
  • Cell therapy research and technology
    • Overview of cell therapy
    • Overview of stem cells
    • Towards the use of cell therapy
    • Cell therapy production
    • Recent developments in cell therapy production
    • The International Cell Therapy Banking Initiative project

Clinical disorders and treatment needs

  • Overview of cancer treatment needs
    • Melanoma
    • Pancreatic cancer
    • Haematopoiesis
  • Cardiovascular and vascular
    • Congestive heart failure
    • Heart attack
    • Dysfunctional heart valves
    • Peripheral vascular disorders
      • Abdominal aortic aneurysm
      • Brain aneurysm
    • Ischemic stroke
  • Autoimmune diseases
    • Graft versus host disease (GvHD)
  • Orthopaedics
    • Non-union fractures
    • Cartilage and connective tissue damage and repair
    • Ligament damage
    • Vertebral disc damage
    • Osteoarthritis
  • Urological
    • Corporal bodies
    • Urethra
    • Bladder
  • Skin, integumentary system
    • Wound healing
    • Hair
  • Dental
    • Missing teeth
    • Gum disease
  • Organ replacement and repair
    • Pancreas
      • Diabetes mellitus
    • Lung
    • Liver
    • Kidney
  • Ophthalmology
    • Cornea
    • Retina
  • General, gastrointestinal, gynaecological and other
    • Crohn’s disease
    • Nerve and neurological conditions
    • Ear repair or replacement
    • Nose repair or replacement
    • Esophagus
    • Trachea
    • Stomach
    • Small intestine
    • Large intestine
    • Bladder
    • Uterus
    • Cervix
    • Penis
    • Other

Tissue engineering and cell therapy developments by clinical area

  • Developments with applications in most or all clinical areas
    • Biodegradable scaffold design for delivery of cells, factors
    • 4-D tissue engineering
  • Cancer
  • Cardiovascular and vascular
  • Orthopaedics
  • Urology
  • Periodontics
  • Organ replacement and repair
  • Ophthalmology
  • General, gastrointestinal, gynaecological and other
  • Overview of key tissue engineering and cell therapy clinical trials

Global regulatory and reimbursement landscape

  • Regulatory
  • Reimbursement
  • Intellectual property and key patents
    • Stem cell patents
      • The patentability of stem cell lines
      • Individual country policies
    • Tissue engineering and cell therapy patents

Tissue engineering and cell therapy industry overview

  • Intensity of competition
  • Merger and acquisition activity
  • Market dynamics
  • Growth drivers and restraints
  • Investment levels
  • Opportunities in tissue engineering and cell therapy

Global markets for tissue engineering and cell therapy

  • Global market for tissue engineering and cell therapy
    • US market for tissue engineering and cell therapy
    • European Union market for tissue engineering and cell therapy
    • Japan market for tissue engineering and cell therapy
    • Rest of World market for tissue engineering and cell therapy
  • Global market for cancer related tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World
  • Global market for cancer tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World
  • Global market for cardiovascular and vascular tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World
  • Global markets for autoimmune tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World
  • Global markets for orthopaedic tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World
  • Global markets for urological tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World
  • Global markets for skin/ integumentary tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World
  • Global markets for dental tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World
  • Global markets for organ replacement and repair tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World
  • Global markets for ophthalmology tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World
  • Global markets for general, gastrointestinal, gynaecological and other tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World

Company profiles  

Tables and Figures

  • Summary markets, 2014–2025
  • Summary market shares, 2014
  • Incidence of
    • Congestive heart failure
    • Myocardial infarction
    • Dysfunctional heart valves
  • Incidence & prevalence of
    • Melanoma
    • Pancreatic cancer
    • Leukaemia
    • Peripheral vascular disorders
    • Abdominal aortic aneurysm
    • Brain aneurysm
    • Ischemic stroke
    • Graft vs. host disease
    • Non-union fractures incidence
    • Cartilage and connective tissue damage
    • Vertebral disc damage
    • Osteoarthritis
    • Difficult-to-heal wounds
    • Baldness
    • Periodontal diseases
    • Diabetes mellitus
    • Lung disease
    • Liver disease
    • Kidney disease
    • Corneal disease
    • Retinitis pigmentosa
    • Age-related macular degeneration
    • Crohn’s disease
    • Amyotrophic lateral sclerosis
    • Parkinson’s disease
    • Epilepsy
    • Spinal cord injury
    • Multiple sclerosis
  • Product/technology innovations applicable to broad clinical areas
  • Product/technology innovations with
    • Cancer treatment applications
    • Cardiovascular and vascular treatment applications
    • Orthopaedic treatment applications
    • Urological treatment applications
    • Periodontal applications
    • Applications in organ replacement and repair
    • Applications in ophthalmology
  • Product/technology innovations applicable to general, gastrointestinal, gynaecological and other treatments
  • Key elements of regulatory requirements of cell-based tissue engineering and cell therapy by country
  • Key elements of reimbursement for cell-based tissue engineering and cell therapy by country
  • Key tissue engineering and cell therapy patents
  • Drivers & restraints in tissue engineering and cell therapy
  • Global market for tissue engineering and cell therapy, 2014–2025
  • Market for tissue engineering and cell therapy, 2014–2025
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world
  • Global market for cancer-related tissue engineering and cell therapy, 2014–2025
  • Market for cancer-related tissue engineering and cell therapy, 2014–2025
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world
  • Global market for cardiovascular & vascular related tissue engineering and cell therapy, 2014–2025
  • Market for cardiovascular & vascular related tissue engineering and cell therapy, 2014–2025
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world
  • Global market for autoimmune tissue engineering and cell therapy, 2014–2025
  • Market for autoimmune tissue engineering and cell therapy, 2014–2025
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world
  • Global market for orthopaedic tissue engineering and cell therapy, 2014–2025
  • Market for orthopaedic tissue engineering and cell therapy, 2014–2025
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world
  • Global market for neurological tissue engineering and cell therapy, 2014–2025
  • Market for neurological tissue engineering and cell therapy, 2014–2025
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world
  • Market for urological tissue engineering and cell therapy, 2014–2025
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world
  • Global market for skin / integumentary tissue engineering and cell therapy, 2014–2025
  • Market for skin/integumentary tissue engineering and cell therapy, 2014–2025
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world
  • Global market for dental tissue engineering and cell therapy, 2014–2025
  • Market for dental tissue engineering and cell therapy, 2014–2025
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world
  • Global market for organ replacement & repair tissue engineering and cell therapy, 2014–2025
  • Market for organ replacement & repair tissue engineering and cell therapy, 2014–2025
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world
  • Global market for ophthalmological tissue engineering and cell therapy, 2014–2025
  • Market for ophthalmological tissue engineering and cell therapy, 2014–2025
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world
  • Global market for general, GI, GYN & other tissue engineering and cell therapy, 2014–2025
  • Market for general, GI, GYN & other tissue engineering and cell therapy, 2014–2025
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world